Interpretation of Biomarkers Using Pharmacokinetic Modeling
Published Date
Agency
CFDA
66.509
Contact Information
Kacee Deener, 202-343-9852; deener.kathleen@epa.gov
Deadline
Department
Eligiblity
State, local and tribal governments, institutions of higher education and 501(c)(3) nonprofit organizations
Guide Page Reference
none
More Information
Program Area
Programe Purpose
To develop and use physiologically-based pharmacokinetic modeling for the interpretation of biomarker data
